Nachrichten zur Pfizer Inc. Aktie

Ihre wichtigsten Termine: Frische Q3-Zahlen von: Alphabet, Visa, PayPal, McDonalds, Pfizer und Lufthansa

Pfizers Q3 Earnings Beat, Paxlovid Drives Sales Guidance Increase

PFE beats third-quarter estimates for earnings and sales. It raises 2024 earnings and revenue expectations.…

Ausblick: Pfizer verkündet Quartalsergebnis zum jüngsten Jahresviertel

Pfizer wird am 29.10.2024 in der Finanzkonferenz die Quartalszahlen zum jüngsten Jahresviertel - Abschlussdatum 30.09.2024 - vorstellen.Im Durchschnitt erwarten 16…

Pfizer management looks to show turnaround as Starboard looms

…

Pfizer management looks to show turnaround as Starboard looms By Reuters

Pfizer management looks to show turnaround as Starboard looms…

Will Non-COVID Drugs Again Boost Pfizers Top Line in Q3 Earnings?

Pfizers non-COVID drugs and contributions from new and newly acquired products are likely to have driven top-line growth in the…

These 7 Blunt Words Just Opened a Can of Worms For Pfizers Stock

The companys problems are no longer deniable.…

These 7 Blunt Words Just Opened a Can of Worms For Pfizers Stock @themotleyfool #stocks $PFE

The companys problems are no longer deniable.…

These 7 Blunt Words Just Opened a Can of Worms For Pfizers Stock

…

Motley Fool: Dividends can pile up for patient Pfizer investors

Pfizer faces challenges after demand for the COVID vaccine waned, but it has planned for this moment and is finishing…

Pfizer’s Activist Battle Might Fizzle—but Its Stock Probably Won’t

…

Kurs der Pfizer-Aktie verharrt auf Vortags-Niveau (26,3467 €)

Der Kurs der der Pfizer-Aktie kommt kaum von der Stelle. Der jüngste Kurs betrug 28,46 US-Dollar. Einen geringen Wertverlust von…

Pfizer Neutral

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Pfizer auf "Neutral" mit einem Kursziel von 30…

JPMORGAN stuft PFIZER INC auf Neutral

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Pfizer auf "Neutral" mit einem Kursziel von 30…

JPMorgan belässt Pfizer auf Neutral - Ziel 30 Dollar

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Pfizer auf "Neutral" mit einem Kursziel von 30…

A Pfight At Pfizer

…

Pfizer Q3 Preview: Why The Stock Is A Buy Ahead Of Earnings

…

The Zacks Analyst Blog Highlights Novo Nordisk, Novartis, Pfizer, Regeneron and Biogen

Novo Nordisk, Novartis, Pfizer, Regeneron and Biogen are included in this Analyst Blog.…

Biotech mit Überraschungspotenzial - Bayer, BioNTech, CureVac, Medigene, Pfizer Aktie

Die hohe Volatilität im Biotech-Sektor zieht einige Investoren magisch an, während andere Investoren diesen Spezialmarkt lieber meiden. Doch wenn die…

The Zacks Analyst Blog Highlights Novo Nordisk, Novartis, Pfizer, Regeneron Pharmaceuticals and Biogen

Novo Nordisk, Novartis, Pfizer, Regeneron Pharmaceuticals and Biogen are included in this Analyst Blog.…

FDA approves Pfizers RSV vaccine for adults at increased risk of the disease

The U.S. Food and Drug Administration on Tuesday approved Pfizers RSV vaccine for the prevention of lower respiratory tract disease caused by…

Starboard Value CEO Jeff Smith: Pfizer needs to do a better job disciplining itself on investments

Jeff Smith, Starboard Value CEO, joins CNBCs Squawk on the Street to discuss how he sees Pfizer going forward, potential…

Starboard Value CEO says Pfizers board should hold management accountable By Reuters

Starboard Value CEO says Pfizers board should hold management accountable…

Is Pfizers Attractive Valuation Enough to Invest in the Stock?

PFEs non-COVID drugs and potential contributions from new and newly acquired products have started to drive growth.…

The Zacks Analyst Blog Highlights Johnson & Johnson, Pfizer, Roche, AbbVie and Sanofi

Johnson & Johnson, Pfizer, Roche, AbbVie and Sanofi are included in this Analyst Blog.…

Pfizer: Activists Clouding A Promising Picture

…

Pfizer Aktie: Portfolio-Neugestaltung entscheidend für zukünftiges Wachstum - Ersteinschätzung

New York (www.aktiencheck.de) - Pfizer-Aktienanalyse von Sanford C. Bernstein & Co: Aktuelle Bewertung Bernstein-Analystin, Courtney Breen, hat die Coverage von Pfizer Inc.…

Pharma Stock Roundup: JNJs Q3 Earnings, FDA Nod to Some New Drugs

J&J tops third-quarter earnings and sales estimates. FDA approves new drugs of Pfizer, Roche and AbbVie.…

Why Im Considering Leaning Heavily Into Pfizer @themotleyfool #stocks $PFE

Pfizers high dividend yield and robust pipeline could offer significant returns for patient investors.…

Why Im Considering Leaning Heavily Into Pfizer

…

Why Im Considering Leaning Heavily Into Pfizer

Pfizers high dividend yield and robust pipeline could offer significant returns for patient investors.…

Pfizer taps Vanguard veteran for board amid fight with Starboard By Reuters

Pfizer taps Vanguard veteran for board amid fight with Starboard…

Pfizer Is Clashing With Its New Activist Investor. Will It Harm The Stock? @themotleyfool #stocks $PFE

This investors campaign is stoking some undesirable corporate intrigue.…

Pfizer Is Clashing With Its New Activist Investor. Will It Harm The Stock?

This investors campaign is stoking some undesirable corporate intrigue.…

Which Pharma Stock Is the Better Bargain Buy: Pfizer or Eli Lilly? @themotleyfool #stocks $PFE $LLY

These two stocks will appeal to very different types of investors at the moment.…

Which Pharma Stock Is the Better Bargain Buy: Pfizer or Eli Lilly?

These two stocks will appeal to very different types of investors at the moment.…

wO Börsenlounge - die Woche: Einstiege, Übernahmen, ein "Robotaxi-Event" und der Einbruch der China-Aktien

Neben dem Start in die Berichtssaison scheint auch das Übernahmekarussell wieder in Fahrt zu kommen. Bei Pfizer ist ein Hedgefonds…

An Activist Investor Just Bought $1 Billion Worth of Pfizer. Heres What It Means for the Stock

There may be changes coming to this company, if the activists get their way.…

An Activist Investor Just Bought $1 Billion Worth of Pfizer. Heres What It Means for the Stock @themotleyfool #stocks $PFE

There may be changes coming to this company, if the activists get their way.…

dpa-AFX ProFeed